MedPharm

Executive Summary

MedPharm is a UK-based contract development and manufacturing organization (CDMO) specializing in topical and transdermal drug delivery. Founded in 1999 and headquartered in Guildford, the company provides comprehensive clinical supply services, including manufacturing, testing, and logistics, to support investigational therapies through clinical trials. With over two decades of experience, MedPharm has established itself as a reliable partner for dermatology and drug delivery programs, focusing on precision and regulatory compliance to ensure the viability, safety, and efficacy of its clients' drug products. While the company operates in a niche but growing market, its private status and lack of recent public disclosures limit visibility into its financial performance and pipeline. Nonetheless, MedPharm's long track record and specialization position it well to benefit from increasing demand for topical and transdermal formulations, particularly as more biologics and small molecules require advanced delivery systems.

Upcoming Catalysts (preview)

• TBDAnnouncement of Major New Clinical Supply Contract50% success
• TBDExpansion of Manufacturing Capacity or Facility40% success
• TBDPartnership or Collaboration with a Large Pharma for Transdermal Delivery30% success